The World Anti-Doping Agency's (WADA) mission is to promote, coordinate and monitor the fight against doping in sport in all its forms.

WADA was established in 1999 as an international independent agency composed and funded equally by the sport movement and governments of the world. Its key activities include scientific research, education, development of anti-doping capacities, and monitoring of the World Anti Doping Code (Code) – the document harmonizing anti-doping policies in all sports and all countries. WADA is a Swiss private law Foundation. Its seat is in Lausanne, Switzerland, and its headquarters are in Montreal, Canada.

WADA works towards a vision of the world that values and fosters a doping-free culture in sport.

World Anti-Doping Code                                   

The Code is the core document that provides the framework for harmonized anti-doping policies, rules and regulations within sport organizations and among public authorities. It works in conjunction with five International Standards aimed at bringing harmonization among anti-doping organizations in various areas: testing, laboratories, Therapeutic Use Exemptions (TUEs), the List of Prohibited Substances and Methods, and for the protection of privacy and personal information. The last revisions to the Code took effect on January 1, 2009.

2010 Prohibited List                              2011 Prohibited List
 

The Prohibited List (List) was first published in 1963 under the leadership of the International Olympic Committee. Since 2004, as mandated by the World Anti-Doping Code (Code), WADA is responsible for the preparation and publication of the List. The List is a cornerstone of the Code and a key component of harmonization. It is an International Standard identifying substances and methods prohibited in-competition, out-of-competition and in particular sports. Substances and methods are classified by categories (e.g., steroids, stimulants, gene doping). The use of any prohibited substance by an athlete for medical reasons is possible by virtue of a Therapeutic Use Exemption (TUE).

World Anti-Doping Agency Athlete Guide (5th edition)

Doping Control Leaflet